AI-designed protein shows 50% greater anti-inflammatory effect in animal studies
A research team has developed a next-generation anti-inflammatory protein using AI and supercomputing.
Dec 29, 2025
0
6
MeSH tree: D12.776.467
A research team has developed a next-generation anti-inflammatory protein using AI and supercomputing.
Dec 29, 2025
0
6
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and ...
Dec 23, 2025
0
0
Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer. Current antiviral therapies suppress viral replication but do not eliminate the virus, highlighting ...
Dec 23, 2025
0
0
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has developed a new class of engineered extracellular vesicles (EVs) capable of inducing antigen-specific ...
Dec 22, 2025
0
0
Scientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may begin in early life, a drug long-approved for other conditions might be repurposed to slow this damage, ...
Dec 20, 2025
0
95
Acute systemic inflammation has long been suspected to trigger harmful processes within the brain, contributing to neurodegenerative disorders such as Alzheimer's and Parkinson's disease. A new study published online in the ...
Dec 19, 2025
0
0
mRNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are produced through specialized immune structures called germinal centers, but until now it was not fully ...
Dec 17, 2025
0
0
In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.
Dec 16, 2025
0
21
The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory biomaterial-based cancer vaccine, in a cohort of 21 patients with stage 4 metastatic melanoma, was concluded with ...
Dec 15, 2025
0
0
Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has successfully developed ...
Dec 15, 2025
0
71